Search results
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 58 minutes agoLilly said in May...decline by 22% using one measure. In the Phase 3 study, 1.6% of patients...
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 4 hours agoHowever, in January 2024, Biogen discontinued the development and commercialization of Aduhelm as...
FDA Panelists Unanimously Back Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 20 hours agoAll 11... Are Key Donanemab, like Biogen and Eisai's Leqembi, works by removing built-up...imaging...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 21 hours agoS. later this year. The FDA typically follows the recommendations of its advisory panels but is not...
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
Benzinga· 5 days agoIn March last year, Eli Lilly released the results of the TRAILBLAZER-ALZ 2 Phase 3 study of...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 4 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 5 days agoIt’s a lot to unpack, but many of the issues raised were already on Lilly’s radar. The Peripheral...
Lilly's donanemab sails through FDA meeting with 2 unanimous votes in favor
FierceBiotech· 20 hours agoDo the available data show that donanemab is effective for the treatment of Alzheimer’s disease in...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
Benzinga· 2 days agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) ...
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
InvestorPlace· 5 days agoPharma stocks have two unique characteristics that can make them great investments for many...